| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | Chief Financial Officer | $0 | -$1.22M | -100% | Jul 31, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
|---|